EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances with Lipid-Based Nanosystems for siRNA Delivery to Breast Cancers

Md Abdus Subhan iD, Nina Filipczak iD, Vladimir P Torchilin

Pharmaceuticals · 06.07.2023 · 16 (7) · 970

DOI: 10.3390/ph16070970 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 06.07.2023. Verfasst von Md Abdus Subhan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, ShahJalal University of Science and Technology, Sylhet 3114, Bangladesh. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer is the most frequently diagnosed cancer among women. Breast cancer is also the key reason for worldwide cancer-related deaths among women. The application of small interfering RNA (siRNA)-based drugs to combat breast cancer requires effective gene silencing in tumor cells. To overcome the challenges of drug delivery to tumors, various nanosystems for siRNA delivery, including lipid-based nanoparticles that protect siRNA from degradation for delivery to cancer cells have been developed. These nanosystems have shown great potential for efficient and targeted siRNA delivery to breast cancer cells. Lipid-based nanosystems remain promising as siRNA drug delivery carriers for effective and safe cancer therapy including breast cancer. Lipid nanoparticles (LNPs) encapsulating siRNA enable efficient and specific silencing of oncogenes in breast tumors. This review discusses a variety of lipid-based nanosystems including cationic lipids, sterols, phospholipids, PEG-lipid conjugates, ionizable liposomes, exosomes for effective siRNA drug delivery to breast tumors, and the clinical translation of lipid-based siRNA nanosystems for solid tumors.

Schlagwörter

Stichwörter der Autor:innen

breast cancergene silencinglipid NPspersonalized therapysiRNA delivery

Autor:innen und Institutionen

  • Department of Chemistry, ShahJalal University of Science and Technology, Sylhet 3114, Bangladesh.
  • Division of Nephrology, University of Rochester Medical Center, School of Medicine and Dentistry, 601 Elmwood Ave, Box 675, Rochester, NY 14642, USA.
  • Center for Pharmaceutical Biotechnology and Nanomedicine, Department of Pharmaceutical Sciences, Northeastern University, Boston, MA 02115, USA.
  • Department of Chemical Engineering, Northeastern University, Boston, MA 02115, USA.

ORCID-Profile: Md Abdus Subhan, Nina Filipczak

Zitieren

APA

Subhan, M. A., Filipczak, N., & Torchilin, V. P. (2023). Advances with Lipid-Based Nanosystems for siRNA Delivery to Breast Cancers. Pharmaceuticals, 16(7), 970. https://doi.org/10.3390/ph16070970

Vancouver

Subhan MA, Filipczak N, Torchilin VP. Advances with Lipid-Based Nanosystems for siRNA Delivery to Breast Cancers. Pharmaceuticals. 2023;16(7):970. doi:10.3390/ph16070970

BibTeX
@article{Subhan2023,
  author = {Subhan, Md Abdus and Filipczak, Nina and Torchilin, Vladimir P},
  title = {Advances with Lipid-Based Nanosystems for siRNA Delivery to Breast Cancers},
  journal = {Pharmaceuticals},
  year = {2023},
  volume = {16},
  number = {7},
  pages = {970},
  doi = {10.3390/ph16070970}
}
Kostenlos starten →